NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
1
- NATURE OF OPERATIONS
COMPANY
OVERVIEW
ZIM
Corporation (“ZIM” or the “Company”) is a provider of software products and services for the database
and mobile markets. ZIM products and services are used by enterprises in the design, development and management of business, database
and mobile applications. ZIM also provides mobile content to the consumer market.
BUSINESS
DEVELOPMENT
ZIM
was formed under the laws of Canada on October 17, 2002, in order to purchase ZIM Technologies International Inc. (“ZIM
Technologies”), which was formed in 1997 to acquire the software technology now called the ZIM Integrated Development Environment
(the “ZIM IDE software”). On February 10, 2004, ZIM purchased UK-based short messaging service (“SMS”)
firms EPL Communications Limited and E-Promotions Limited (together referred to as “EPL”). During the fiscal year
ended March 31, 2006, EPL was dissolved and all operations were transferred to ZIM Corporation in Canada. ZIM is also the sole
shareholder of ZIM Technologies do Brazil Ltda., a company incorporated in Brazil that distributes the ZIM IDE Software, and PCI
Merge, Inc., a Florida based holding company with no operations. Until March 31, 2004, ZIM was the sole shareholder of ZIM Technologies,
a Canadian federal corporation and the chief operating company of the ZIM group of companies. On April 1, 2004, ZIM Corporation
and ZIM Technologies amalgamated into ZIM Corporation. On April 1, 2006, ZIM purchased a US-based mobile content company called
Advanced Internet Inc. (“AIS”). In April 2016, ZIM incorporated a wholly owned subsidiary called GeneSpans Corporation.
GeneSpans is focused on developing intellectual property and advancing research and development
in the areas of new synthetic drugs and immunotherapies. Genespans name was changed to NuvoBio Corporation
on August 25, 2016.
BUSINESS
OF THE COMPANY
ZIM
started operations as a developer and provider of database software known as ZIM IDE software. ZIM IDE software is used by companies
in the design, development, and management of information databases and mission critical applications. The Company continues to
provide this software and support services to its client base.
Beginning
in 2002, the Company expanded its business to include opportunities associated with mobile products. Prior to fiscal
2007, the Company focused on developing products and services for the wireless data network infrastructure known as “SMS”
or “text messaging”. Although SMS will continue to provide a minimal amount of revenue within the mobile segment
of ZIM’s operations, with the acquisition of AIS, the Company shifted its corporate focus to include offering mobile content
directly to end users. In fiscal 2008, ZIM added the ZIM TV service and in partnership with the International Table
Tennis Federation (“ITTF”) provided development and hosting services for IPTV to ITTF end users. However, due to low
sales volumes ZIM exited this market in fiscal 2009.
In
fiscal 2020, ZIM continued to develop and sell enterprise database software to end users as well as maintain its SMS messaging
business. At March 31, 2013 ZIM discontinued the sale of mobile content.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2019
(EXPRESSED IN US DOLLARS)
Also,
in 2017, NuvoBio signed strategic partnerships and exclusive global licensing agreements with leading drug research institutes
and companies. The Company is currently funding research and development projects in the following areas:
|
New
peptide-derived inhibitors for therapeutic intervention against various cancer cell lines in the presence or absence of
chemotherapeutics to characterize the in vivo effects of promising inhibitors.
|
These
consolidated financial statements have been prepared on a going concern basis in accordance with accounting principles generally
accepted in the United States ("US GAAP").The going concern basis of preparation assumes that the Company will
continue in operation for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments
in the normal course of business. The Company had an operating loss and negative cash flows
from operations during the year ended March 31, 2020, the Company has incurred an accumulated deficit of $20,631,105 to
date as a result of its history of operating losses and negative cash flows
from operations in prior years. This raises substantial doubt about the ability of
the Company to continue as a going concern. The ability of the Company to continue as a going concern and to realize the carrying
value of its assets and discharge its liabilities and commitments when due is
dependent on the Company generating revenue sufficient to fund its cash flow needs. There is no certainty that this and
other strategies will be sufficient to permit the Company to continue as a going concern.
Management is currently investigating and evaluating options that may include recapitalization of the Company and pursuing other
ventures of a different nature.
The consolidated financial statements do not reflect adjustments that would be necessary if
the going concern assumption was not appropriate. If the going concern assumption
was not appropriate for these consolidated financial statements, then adjustments could be necessary to the carrying
values of the assets and liabilities, the reported revenue and expenses and the classifications used in the consolidated balance
sheets. Such adjustments could be material.
THE
COVID-19 PANDEMIC HAS ADVERSELY IMPACTED, AND POSES RISKS TO, OUR BUSINESS, THE NATURE AND EXTENT OF WHICH ARE HIGHLY UNCERTAIN
AND UNPREDICTABLE.
In
recent months, the continued, global spread of COVID-19 has led to disruption and volatility in the global capital markets, which
has increased the cost of, and adversely impacted access to, capital (including the commercial paper markets) and increased economic
uncertainty. It is likely that the pandemic will cause an economic slowdown of potentially extended duration, and it is possible
that it could cause a global recession.
COVID-19
is adversely affecting, and is expected to continue to adversely affect, certain elements of our business, including as a result
of impacts associated with preventive and precautionary measures that we, other businesses, our communities and governments are
taking. Due to these impacts and measures, we have experienced and expect to continue to experience delays in our internal product
development and unpredictable reductions in demand for certain of our products and services. Our employees have been required
to work from home or not go into their offices. Such restrictions are slowly being lifted. If the pandemic continues and conditions
worsen, we expect to experience additional adverse impacts on our operational and commercial activities and customer orders, which
adverse impacts may be material, and it remains uncertain what impact these adverse impacts would have on future sales and customer
orders even if conditions begin to improve.
ZIM
CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE YEAR ENDED MARCH 31, 2019
(EXPRESSED
IN US DOLLARS)
Negative
economic conditions may also cause customers in general to reduce their IT spending. Customers may delay or cancel projects, choose
to focus on in-house development efforts or seek to lower their costs by renegotiating maintenance and support agreements. Additionally,
customers may be more likely to make late payments in worsening economic conditions, which could require us to increase our collection
efforts and require us to incur additional associated costs to collect expected revenues. To the extent purchases of licenses
for our software are perceived by customers and potential customers to be discretionary, our revenues may be disproportionately
affected by delays or reductions in general IT spending. The extent to which COVID-19 impacts our business will depend on future
developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity
of COVID-19 and the actions to contain COVID-19 or treat its impact, among others.
In
addition to existing travel restrictions, jurisdictions may continue to close borders, impose prolonged quarantines and further
restrict travel and business activity, which could significantly impact our ability to support our operations and customers. Further,
such travel restrictions and slowed-down business activities may affect the operation of our customers and result in decreases
in sales of our products and services, which could adversely affect our financial results. Due to the speed with which the COVID-19 situation
is developing, the global breadth of its spread and the range of governmental and community reactions thereto, there is uncertainty
around its duration and ultimate impact; therefore, any negative impact on our overall financial and operating results (including
without limitation our liquidity) cannot be reasonably estimated at this time, but the pandemic could lead to extended disruption
of economic activity and the impact on our financial and operating results could be material.
3
- SIGNIFICANT ACCOUNTING POLICIES
BASIS
OF PRESENTATION
These
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America ("US GAAP").
PRINCIPLES
OF CONSOLIDATION
These
consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. The
results of operations for acquisitions are included in these consolidated financial statements from the date of acquisition. Inter-company
transactions and balances are eliminated upon consolidation.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
USE
OF ESTIMATES
The
preparation of consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the consolidated financial statements and the reported amount of revenue and expenses during the period. Estimates have been made
by management in several areas, including, but not limited to, the realizability of accounts receivable, the valuation allowance
associated with deferred income tax assets, investment tax credits, the calculations supporting the revaluation of investments,
expected useful life of equipment and the fair value calculation with respect to the stock options. Actual results may differ
from those estimates.
CASH
AND CASH EQUIVALENTS
The
Company considers all highly liquid investments with an original term to maturity of three months or less to be cash equivalents.
ALLOWANCE
FOR DOUBTFUL ACCOUNTS
Accounts
receivable are recorded at the invoiced amount net of an allowance for doubtful accounts. The Company determines its allowance
for doubtful accounts by considering a number of factors, including the age of the receivable, the financial stability of the
customer, discussions that may have occurred with the customer and management's judgment as to the overall collectability of the
receivable from that customer. The Company writes off accounts receivable when they become uncollectible, and payments subsequently
received on such receivables are credited to selling, general and administration accounts in the period of recovery.
REVENUE
RECOGNITION
The
Company derives revenue from two sources: enterprise software, including maintenance and consulting services and mobile services
and applications. Enterprise software involves providing enterprise software for designing, developing and manipulating database
systems and applications. Mobile services involve providing SMS applications and services. The Company presents revenues net of
sales tax and other related taxes.
ENTERPRISE
SOFTWARE REVENUE RECOGNITION
ZIM
records revenues from the perpetual license of the Company's software products and the sale of related maintenance and consulting.
The Company's standard license agreement provides a license to use the Company's products based on the number of licensed users.
The Company may license its software in multiple element arrangements if the customer purchases any combination of maintenance,
consulting or training services in conjunction with the license.
The
Company recognizes revenue pursuant to the requirements of ASC 606, Revenue from Contracts with Customers. Revenue is recognized
using the residual method when evidence of fair value exists for all of the undelivered performance obligations in the arrangement,
but does not exist for one or more performance obligations. The Company allocates revenue to each undelivered performance obligation
based on its respective fair value determined by the price charged when that performance obligation is sold separately. The Company
defers revenue for the undelivered performance obligations and recognizes the residual amount of the arrangement fee, if any.
The separate performance obligations of the arrangements are considered to be separate units of accounting.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
The
following steps are taken to recognize revenue:
|
1.
|
Identification
of the contract(s) with the customer(s).
|
|
2.
|
Identify
the performance obligations in the contract.
|
|
3.
|
Determine
the transaction price.
|
|
4.
|
Allocate
the transaction price to the performance obligations in the contract.
|
|
5.
|
Recognize
revenue when (or as) the Company satisfies the performance obligations.
|
|
|
|
The
Company records revenue as earned as evidenced by contracts or invoices for its services at prices established by contract,
price list and/or fee schedule less applicable discounts and the objective evidence that each performance obligation has been
achieved. If at the outset of an arrangement the Company determines that the probability of collection is less than 100% it
determines the amount expected to be received and books revenue based on that amount. When probability of collection
subsequently changes, a re-assessment of the amount receivable is performed at that time and the appropriate revenue is
recognized.
Collectability
is assessed based on the collection history of the client, current economic trends, customer concentrations and customer credit
worthiness. Delivery of the software has occurred once the customer has accepted the product or has been provided with permanent
keys to the file transfer protocol ("FTP") site. If an arrangement allows for customer acceptance of the software or
services, the Company defers revenue recognition until the earlier of customer acceptance or when the acceptance right lapses.
MAINTENANCE
AND CONSULTING REVENUE RECOGNITION
Maintenance
revenues are recognized using a time-based approach equally over the term of the maintenance contract. The liability relating
to the received but unearned portion of maintenance revenues is recognized as deferred revenues.
Consulting
revenue, which represents services provided on a per diem basis to customers, is recognized as the services are performed as there
are no customer acceptance provisions involved in these types of arrangements. Consulting revenue, which represents services provided
on a fixed price basis to customers, is recognized upon achieving the related performance obligation.
In
general, credit terms of 30 days are extended to customers with a small number of customers receiving longer payment terms based
on the long-standing relationship with ZIM.
MOBILE
REVENUE RECOGNITION
Aggregation
services occur when ZIM sends messages from its content provider customers through mobile operators to end users on their cell
phones. In this situation, the Company contracts with its customers that cannot connect directly to the mobile operators and with
the third-party mobile operators or other aggregators directly for the transmission of the messages. The performance obligation
is to transmit a message. Revenues are recognized in the month in which the performance obligation is satisfied, provided no significant
ZIM obligations remain. We work with aggregators to provide delivery routes and receive statements and billing in real time. We
prepay for message credits and bill customers for message delivery at the end of each month. We purchase service credits from
the aggregators and bill our customers directly for the delivery of messages on a monthly basis.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
RESEARCH
AND DEVELOPMENT EXPENSES
Costs
related to research, design and development of products and applications are charged to research and development expense as incurred.
Software development costs are capitalized beginning when a product's technological feasibility has been established, which generally
occurs upon completion of a working model, and ending when a product is available for general release to customers. All subsequent
costs are expensed as incurred. To date, completing a working model of the Company's products and the general release of the products
has substantially coincided. The Company has not capitalized any software development costs since such costs have not been significant.
The
Company qualifies for scientific research and experimental development refundable investment tax credits. These credits are recorded
as a reduction of research and development expense when it is more likely than not that the credits will be realized. Other non-refundable
investment tax credits not utilized in the current year will be used to offset income taxes otherwise payable in future years
and will be accounted for as a reduction in income tax expense.
TRANSLATION
OF FOREIGN CURRENCIES
The
Company's reporting currency is the U.S. dollar and the functional currency is the Canadian dollar for ZIM Corporation and NuvoBio,
U.S. Dollar for AIS and Brazilian Reals for ZIM do Brazil.
Transactions
denominated in currencies other than the functional currency of the Company or its subsidiaries are initially measured using the
exchange rate in effect on the date of the transaction. At each balance sheet date, monetary assets and liabilities are remeasured
into the functional currency using the exchange rate in effect on that date. Any foreign exchange gains or losses resulting from
this remeasurement are recognized in the statement of income (loss) and comprehensive income (loss) of the respective entity for
that period. For the years ended March 31, 2020, 2019, and 2018, the Company recognized a foreign exchange gain (loss) of $1,075,
7,221, and ($2,504), respectively, in the accompanying consolidated statements of income (loss) and comprehensive income (loss)
included in the selling, general and administrative expenses.
The
translation of the Company's financial statements and those of its subsidiaries from their respective functional currencies to
the Company’s reporting currency is performed as follows: all assets and liabilities are translated into U.S. dollars at
the rate of exchange in effect at the balance sheet date. Equity transactions and cash flows related to investing and financing
activities are translated at the exchange rate in effect at the date of the transaction. Revenues, expenses and cash flows related
to operating activities are translated at the weighted average exchange rates for the period. The resulting translation adjustments
are included in accumulated other comprehensive income (loss) in shareholders' equity. The translation adjustments did not result
in a tax impact.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
INCOME
TAXES
Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax basis and operating loss and tax credit carry-forwards using enacted tax rates and laws in effect in
the year in which the differences are expected to reverse. When necessary, a valuation allowance is recorded to reduce the tax
assets to an amount for which realization is more likely than not. The effect of changes in tax rates is recognized in the period
in which the rate change occurs.
The
Company is subject to examination by taxing authorities in the jurisdictions of Canada, Brazil and the United States. Management
does not believe that there are any uncertain tax positions that would result in an asset or liability for taxes being recognized
in the accompanying consolidated financial statements.
EARNINGS
PER SHARE
Basic
earnings per share are computed by dividing net earnings available to common shareholders by the weighted average number of common
shares outstanding during the reporting period. Diluted earnings per share are calculated giving effect to the potential dilution
that could occur if securities or other contracts to issue common shares were exercised or converted to such shares at the later
of the beginning of the period or the issuance date. The treasury stock method is used to determine the dilutive effect of warrants
and stock options. The treasury stock method assumes that proceeds received from the exercise of in-the-money share purchase warrants
and stock options are used to repurchase common shares at the average market price during the period.
STOCK
OPTIONS AND GRANTS
Compensation
cost for all stock-based awards is measured at fair value on the date of grant and recognized as compensation expense over the
service period for awards expected to vest. Stock-based awards granted to consultants are measured at fair value on the grant
date and compensation expense is recognized on the date at which the consultant's performance is complete which, for the Company,
is on the date of grant.
The
fair value of stock options is determined using the Black Scholes-Merton option pricing model. The expected dividend yield is
based on historical dividend payouts, the expected volatility is based on historical volatilities of company stock (management
believes that the historical volatility is an appropriate measure of expected volatility) for a period approximating the expected
life; the risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with
the expected life of the option; and the expected life represents the period of time the options are expected to be outstanding
and is based on historical trends. The weighted average assumptions used in the computations are as follows:
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
|
|
Year ended
March 31, 2020
|
|
Year ended
March 31, 2019
|
|
Year ended
March 31, 2018
|
|
|
|
Risk-free interest rates
|
|
|
1.49
|
%
|
|
|
2.52
|
%
|
|
|
1.93
|
%
|
Expected volatility
|
|
|
284
|
%
|
|
|
120
|
%
|
|
|
433
|
%
|
Dividend yield
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Expected life of options (years)
|
|
|
3.0
|
|
|
|
3.0
|
|
|
|
3.0
|
|
EQUIPMENT
Equipment
is recorded at cost net of depreciation and any impairment losses. Depreciation is provided over the estimated useful lives of
the underlying assets using the following methods and rates:
Computer equipment
|
|
40%
|
|
Declining balance
|
Software
|
|
40%
|
|
Declining balance
|
Office furniture and equipment
|
|
20%
|
|
Declining balance
|
Voice communications equipment
|
|
20%
|
|
Declining balance
|
Leasehold improvements
|
|
5 years
|
|
Straight line over the
lesser of 5 years or
the term of
the
underlying lease
|
IMPAIRMENT
OF EQUIPMENT
Equipment
is tested for impairment whenever events or changes in circumstances indicate that the Company may not be able to recover the
net book value of its productive assets, If the carrying value of these assets is not recoverable, the assets are deemed impaired
and are to be written down to their estimated fair value through a charge to earnings. The guidance states that fair values may
be estimated using discounted cash flow analysis or quoted market prices, together with other available information. The Company
reviewed its property and equipment assets for impairment to determine if there were events or changes in circumstances that would
indicate that the carrying amount of the assets may not be recoverable through future cash flows. It was determined that no impairment
was evident.
INVESTMENTS
ZIM
measures the value of its equity investments in privately-held companies, which do not have readily determinable fair values,
using the alternative measurement basis permitted under Accounting Standards Update (“ASU”) 2016-01, Financial
Instruments – Overall: Recognition and Measurement of Financial Assets and Financial
Liabilities. Under this alternative measurement basis, equity investments in privately-held companies without readily
determinable fair values are measured at cost, less any impairments, plus or minus any adjustments resulting from observable price
changes in orderly transactions for the identical or similar investment of the same issuer. In the absence of observable price
changes, the alternative measurement basis of cost less any impairments is used as a valuation methodology.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
ACCOUNTING
PRONOUNCEMENTS ADOPTED
In
January 2016, the FASB issued Accounting Standards Update 2016-01, Financial
Instruments–Overall: Recognition and Measurement of Financial Assets and Financial Liabilities (the
ASU). Changes to the current GAAP model primarily affects the accounting for equity investments, financial liabilities under the
fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the FASB clarified
guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on
available-for-sale debt securities. The accounting for other financial instruments, such as loans, investments in debt securities,
and financial liabilities is largely unchanged. The classification and measurement guidance will be effective for public business
entities in fiscal years beginning after December 15, 2017. This standard was adopted on April 1, 2018 as the company assessed
any change in the fair value of investments. The effect
of the adoption of this standard was an increase in the carrying value of the Equispheres investment at April 1, 2018 of $604,013
to a value of $721,122.
In
November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230) – Restricted Cash. This will require entities
to show the changes in the total cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash
flows. These changes became effective for ZIM on April 1, 2019. The adoption of this standard had no impact on the consolidated
financial statements of the Company.
In
August 2016 the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) – Classification of Certain Cash Receipts and
Cash Payments. This standard provides guidance on presentation and classification of certain cash receipts and payments in the
statement of cash flows. These changes became effective for ZIM on April 1, 2019. The adoption of this standard had no impact
on the consolidated financial statements of the Company.
In February
2016, the FASB issued Accounting Standards Update 2016-02, “Leases (Topic 842)” (“ASU 2016-02”) and issued
subsequent amendments to the initial guidance during 2018, collectively referred to as “ASC 842”. These updates supersede
the lease guidance in ASC Topic 840, “Leases” (“ASC 840”) and require the recognition of lease assets
and lease liabilities by lessees for most leases previously classified as operating leases under ASC Topic 840. Leases will continue
to be classified as either operating or finance. ASC 842 is effective for annual periods, and interim periods within those annual
periods, beginning after December 15, 2018, which is our fiscal year that began on April 1, 2019 (fiscal 2020). The Company adopted
ASC 842 as of April 1, 2019 using the cumulative effect method and therefore the comparative information has not been restated
and continues to be reported under ASC Topic 840.
The adoption
of ASC 842 resulted in an increase to ROU assets of $1,932 and lease liabilities of $2,084 as of March 31, 2020. The adoption
of ASC 842 did not have a material impact on either our consolidated statement of income (loss) and comprehensive income
(loss).
On adoption
of ASC 842, we have elected to apply the practical expedient to carry forward our current assessments of whether a contract contains
a lease, lease classification, and amounts capitalized as initial direct costs. In addition, we have elected the hindsight practical
expedient to determine lease term for existing leases.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
RECENTLY
ISSUED ACCOUNTING PRONOUNCEMENTS - NOT YET ADOPTED
From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other
standards setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company’s
management believes that the impact of recently issued standards that are not yet effective will not have any significant impact
on the consolidated financial statements upon adoption.
In
June 2016, FASB issued Accounting Standards Update (ASU) 2016-13, Financial Instruments—Credit Losses (Topic 326).
This ASU represents a significant change in the ACL accounting model by requiring immediate recognition of management’s
estimates of current expected credit losses (CECL). Under the prior model, losses were recognized only as they were incurred,
which FASB has noted delayed recognition of expected losses that might not yet have met the threshold of being probable. The
new standard is effective for annual and interim reporting periods beginning after December 15, 2019 for a public business
entity. Early adoption is permitted. We are currently evaluating the impact ASU 2016-13 will have on the Company’s consolidated
financial statements.
4
- ACCOUNTING FOR UNCERTAIN TAX POSITIONS
The
Company recognizes any interest accrued related to unrecognized tax benefits in interest and penalties in income tax benefit in
the consolidated statement of loss and comprehensive loss.
5
- ACCOUNTS RECEIVABLE
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
Trade accounts receivable
|
|
|
31,215
|
|
|
|
65,829
|
|
Allowance for doubtful accounts
|
|
|
(6,666
|
)
|
|
|
(8,560
|
)
|
Other
|
|
|
964
|
|
|
|
2,362
|
|
|
|
|
25,513
|
|
|
|
59,631
|
|
6
– INVESTMENTS
All
investments are in private companies located within Canada.
Investments
and long-term deposits
|
Investment
Date
|
Value
at Investment Date
|
2020
|
2019
|
Available
For Sale
|
CP4H
|
June
29, 2012
|
187,367
|
-
|
-
|
No
|
HostedBizz
|
Dec.
31, 2013
|
1,005
|
-
|
-
|
No
|
Equispheres
Inc.
|
August
26,2016
|
112,752
|
660,816
|
701,564
|
No
|
Spiderwort
|
August
24, 2019
|
7,725
|
10,006
|
7,483
|
No
|
Total
|
|
308,849
|
670,822
|
709,047
|
|
On April
30, 2017, ZIM Corporation made an equity investment in Equispheres Inc. The investment consisted of the purchase of 250,000 common
shares at a price of $20,042.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
On August
26, 2017, ZIM Corporation made an equity investment in Equispheres Inc. The investment consisted of the purchase of 500,000 common
shares at a price of $91,948. Equispheres Inc. is an advanced materials company developing new technologies for the production
of metallic particles for use in additive manufacturing.
On
August 9, 2018, Connecting People for Health Co-operative Ltd. (CP4H) was acquired for an undisclosed amount. ZIM
recognized its portion of the proceeds, in the amount $220,233 as a gain on the sale of assets.
On February
9, 2018 ZIM sold 100,000 shares of HostedBizz to HostedBizz, for cancellation, for gross proceeds of $45,758 United States dollars
($60,000 Canadian dollars).
On August
24, 2019, NuvoBio Corporation made an investment in Spiderwort Inc. The investment consisted of the purchase of a $7,725 U.S.
dollar ($10,000 Canadian dollar) convertible promissory note and is accounted for at amortized cost. The note accrues simple interest
of 5% per annum.
On
October 15, 2019, Spiderwort Inc. completed a qualifying equity financing in an amount greater that $3,000,000 Canadian dollars.
NuvoBio automatically converted securities in Spiderwort to Class B voting common shares. The convertible promissory note converted
into shares of Spiderwort at a value of $10,006 US dollars. This represents an unrealized gain on this equity investment of $2,956.
7
- EQUIPMENT
March 31, 2020
|
|
Cost
|
|
Accumulated depreciation
|
|
Net book value
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computer equipment
|
|
|
785,145
|
|
|
|
778,440
|
|
|
|
6,705
|
|
Software
|
|
|
79,523
|
|
|
|
74,099
|
|
|
|
5,424
|
|
Office furniture and equipment
|
|
|
167,665
|
|
|
|
166,082
|
|
|
|
1,583
|
|
Voice communications equipment
|
|
|
4,297
|
|
|
|
4,128
|
|
|
|
169
|
|
Leasehold improvements
|
|
|
117,004
|
|
|
|
113,660
|
|
|
|
3,344
|
|
|
|
|
1,153,634
|
|
|
|
1,136,409
|
|
|
|
17,225
|
|
March 31, 2019
|
|
Cost
|
|
Accumulated depreciation
|
|
Net book value
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computer equipment
|
|
|
834,420
|
|
|
|
825,004
|
|
|
|
9,416
|
|
Software
|
|
|
80,585
|
|
|
|
77,668
|
|
|
|
2,917
|
|
Office furniture and equipment
|
|
|
178,682
|
|
|
|
176,362
|
|
|
|
2,320
|
|
Voice communications equipment
|
|
|
4,610
|
|
|
|
4,385
|
|
|
|
225
|
|
Leasehold improvements
|
|
|
124,787
|
|
|
|
118,866
|
|
|
|
5,921
|
|
|
|
|
1,223,084
|
|
|
|
1,202,285
|
|
|
|
20,799
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
Depreciation
expense for the year ended March 31, 2020 was $8,867 ($10,575 and $11,341 for the years ended March 31, 2019 and 2018 respectively).
These expenses are included in the cost of revenue account, the selling, general, and administrative expenses and the research
and development account.
8
– LINE OF CREDIT
During
fiscal 2020, a working capital line of credit, in the form of overdraft protection, was available at approximately $35,244 (equivalent
to $50,000 Canadian, the Company’s functional currency) from the Company’s major financial institution. This credit
facility is secured by the Company’s assets. Amounts can be drawn in Canadian funds on this credit facility and bear interest
at the prime rate, as published by the Royal Bank of Canada, plus 2.15% (4.55% at March 31, 2020). Amounts can also be drawn in
United States of America funds on this credit facility and bear interest at the US Base Rate plus 2.15% (5.40% at March 31, 2020).
In
order to maintain the working capital line of credit the Company must maintain a Tangible Net Worth of greater than $150,000 Canadian
dollars (equivalent to $105,731 US dollars) and a ratio of current assets to current liabilities greater than 1.10:1. The Company
was in compliance with these covenants as at March 31, 2020.
As
at March 31, 2020, nothing was drawn down on this line of credit. The line of credit does not have defined expiration or renewal
dates.
9
– ACCRUED LIABILITIES
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
Employee related accruals
|
|
|
23,036
|
|
|
|
19,990
|
|
Trade
|
|
|
3,272
|
|
|
|
1,497
|
|
|
|
|
26,308
|
|
|
|
21,487
|
|
10
– COMMON SHARE ISSUE
The
Company did not issue any common shares, except for those issued as compensation as described in notes 11 and 12, during the years
ended March 31, 2020, March 31, 2019 or March 31, 2018 pursuant to the exercise of stock options by employees and the granting
of stock for executive officers.
On
November 12, 2009, the Board of Directors approved a share repurchase plan. Shares may be repurchased by the Company to a maximum
of $200 per day and $12,000 per quarter. The repurchase program has no expiration date. As of March 31, 2020, no shares have been
repurchased as part of this program.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
11
– RELATED PARTY TRANSACTIONS
No
remuneration has been recorded in these consolidated financial statements for the services of the Chief Executive Officer (CEO)
for the fiscal years 2020, 2019 and 2018 except for the 11,000 post-consolidation shares of common stock, valued at $58, issued
through the fiscal year 2018. The CEO is also a director and the controlling shareholder.
A
director of the Company is a director and principal owner of a company that provides computing and hosting services to ZIM. During
the fiscal year ending March 31, 2020, the Company paid $52,660 for these services (March 31, 2019 - $59,829, March 31, 2018 -
$21,984). At March 31, 2020, included in accounts payable is $5,683 connected to these services as compared to $7,366 at March
31, 2019. From April 1, 2020 to May 31, 2020, the Company paid $3,918 for these services.
An
officer of the Company is the principal owner of a company that provides finance, accounting and bookkeeping services to ZIM.
During the fiscal year ending March 31, 2020 the Company paid $17,778 for these services (March 31, 2019 - $12,821, March 31,
2018 - $12,178). At March 31, 2020, included in accounts payable is $1,919 connected to these services as compared to $2,854 at
March 31, 2019. From April 1, 2020 to May 31, 2020, the Company paid $1,450 for these services.
On
June 5, 2020, ZIM Corporation announced the sale of its database technology business as part of management’s plan to focus
the business on its biomedical subsidiary NuvoBio. The database assets include all of the Software, Consulting and Maintenance
segment and have been purchased by members of Zim Corporation’s staff and will operate under the name Zim Databases Canada
Inc. The purchase price of $84,584 ($120,000 Canadian dollars) is to be paid in 5 equal payments over a 5-year period on the anniversary
date of the agreement.
12
- STOCK BASED COMPENSATION
During
the years ended March 31, 2020 and March 31, 2019 and March 31, 2018 the Company issued common shares options to employees and
non-employees, and as a result, additional paid in capital has been increased by $2,156, $1,807 and $342 respectively.
On
November 22, 2017 Dr. Cowpland, Chief Executive Officer, was awarded a total of 11,000 post-consolidation shares of common stock
in lieu of cash for services provided to the Company, valued at $58.
On
November 22, 2017 a Company controlled by Mr. Stechyson, Chairman of the Board, received a total of 5,000 post-consolidation shares
of common stock in lieu of cash for services provided to the Company, valued at $27.
The
increase in additional paid in capital is the value associated with the granting and the vesting of options, which is recorded
as compensation expense in the statement of income (loss) and comprehensive income (loss) as a part of selling, general and administrative
expense.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
Under
ZIM’s Employee Stock Option Plan, the Company may grant options to its officers, directors and employees for up to 1,360,000
common shares. As at March 31, 2020, options to purchase 161,500 (March 31, 2019, 170,250) were outstanding under the Employee
Stock Option Plan. Stock options are granted with an exercise price equal to the common share’s fair market value at the
date of grant. Options are granted periodically, and both the maximum term of an option and the vesting period are set at the
Board's discretion. All options granted in fiscal year 2020 vested on the day of grant and have a three-year term. The expected
life of the grants due to forfeitures and exercise of options is estimated based on recent history and is 3 years.
The
Company recognized the following expense relating to stock options and grants:
|
|
Year ended
March 31, 2020
|
|
Year ended
March 31, 2019
|
|
Year ended March 31, 2018
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
Options compensation expense for employees
|
|
|
1,506
|
|
|
|
268
|
|
|
|
591
|
|
Options compensation expense for consultants
|
|
|
650
|
|
|
|
1,539
|
|
|
|
468
|
|
Stock grant compensation expense for consultants
|
|
|
—
|
|
|
|
—
|
|
|
|
869
|
|
Stock grant compensation expense for executive officers
|
|
|
—
|
|
|
|
—
|
|
|
|
6,406
|
|
Total expense
|
|
|
2,156
|
|
|
|
1,807
|
|
|
|
8,334
|
|
All
options granted vested on the day of grant resulting in the Company not having any non-vested awards as of March 31, 2020 or March
31, 2019.
A
summary of the status of the stock options is as follows:
|
|
|
|
|
|
|
March 31, 2020
Number of options outstanding
|
|
March 31, 2019
Number of options outstanding
|
|
March 31, 2018
Number of options outstanding
|
|
|
|
|
|
|
|
Options outstanding, beginning of year
|
|
|
170,250
|
|
|
|
204,150
|
|
|
|
225,500
|
|
Granted
|
|
|
33,750
|
|
|
|
79,250
|
|
|
|
48,500
|
|
Expired
|
|
|
(42,500
|
)
|
|
|
(113,150
|
)
|
|
|
(69,850
|
)
|
Options outstanding, end of year
|
|
|
161,500
|
|
|
|
170,250
|
|
|
|
204,150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
share options outstanding at March 31, 2020 are exercisable.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
The
following table represents a summary of the options outstanding as at March 31, 2020:
|
|
|
|
|
Options outstanding and exercisable
|
|
|
Range of exercise prices
|
|
|
|
Number
outstanding at
March 31, 2020
|
|
|
|
Weighted average remaining
contractual life
|
|
|
$
|
|
|
|
|
|
|
|
Years
|
|
|
0.000-0.015
|
|
|
|
79,750
|
|
|
|
0.96
|
|
|
0.015-0.040
|
|
|
|
32,500
|
|
|
|
2.15
|
|
|
0.040-0.080
|
|
|
|
38,000
|
|
|
|
1.89
|
|
|
0.160-0.240
|
|
|
|
11,250
|
|
|
|
2.63
|
|
|
|
|
|
|
161,500
|
|
|
|
1.53
|
|
The
weighted average grant-date fair value of options granted and vested in fiscal years 2020, 2019 and 2018 were $0.0784, $0.0169
and $0.00547 respectively.
As
at March 31, 2020 there were 112,250 options in the money with an intrinsic value of $2,771.
EMPLOYEE
AND NON-EMPLOYEE OPTIONS
During
the year ended March 31, 2020, 15,750 options were granted to employees. In the year ended March 31, 2019, 16,750 options were
granted to employees. In the year ended March 31, 2018, 9,500 options were granted to employees.
During
the year ended March 31, 2020, 18,000 options were granted to non-employees. In the year ended March 31, 2019, 62,500 options
were granted to non-employees. In the year ended March 31, 2018, 39,000 options were granted to non-employees.
No
options have been granted with exercise prices below the market price on the respective grant dates during the years ended March
31, 2020, March 31, 2019 or March 31, 2018.
13
- INTEREST
|
|
Year ended
March 31, 2020
|
|
Year ended
March 31, 2019
|
|
Year ended
March 31, 2018
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
14,398
|
|
|
|
16,334
|
|
|
|
18,526
|
|
Interest expense
|
|
|
(2,237
|
)
|
|
|
(2,378
|
)
|
|
|
(2,934
|
)
|
Total
|
|
|
12,161
|
|
|
|
13,956
|
|
|
|
15,592
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
14
– CONTRACT LIABILITIES
Contract
liabilities relate to deferred revenue from maintenance.
|
|
Years ended
|
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
Balance beginning of the year
|
|
|
89,844
|
|
|
|
60,224
|
|
Aggregate amount of revenue recognized
|
|
|
(178,638
|
)
|
|
|
(365,455
|
)
|
Contract liabilities recognized
|
|
|
146,656
|
|
|
|
395,075
|
|
Balance, end of year
|
|
|
57,862
|
|
|
|
89,844
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2020
|
|
|
|
March 31,
2019
|
|
|
|
|
$
|
|
|
|
$
|
|
Current portion
|
|
|
57,862
|
|
|
|
89,844
|
|
15
- INCOME TAXES
The
Company recognizes in its consolidated financial statements the impact of a tax position if that position is more likely than
not of not being sustained on an audit, based on the technical merits of the position.
The
Company and its subsidiaries file income tax returns in Canadian, Brazilian and U.S. federal jurisdictions, and various provincial
jurisdictions. The Company’s federal income tax returns are generally subject to examination for a period of three years
after filing of the respective return in the U.S. and Canada and five years in Brazil.
Income
tax expense varies from the amount that would be computed by applying the basic federal and provincial income tax rates to income
(loss) before taxes, as follows:
|
|
Year ended March 31, 2020
|
|
Year ended March 31, 2019
|
|
Year ended March 31, 2018
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
Tax Rate, comprised of a federal rate of 9.00% and a provincial rate of 3.43%
|
|
|
12.43
|
%
|
|
|
13.25
|
%
|
|
|
15.13
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Canadian Income Tax (Recovery)
|
|
|
(1,118
|
)
|
|
|
83,562
|
|
|
|
(4,136
|
)
|
Change in valuation allowance
|
|
|
(180,415
|
)
|
|
|
(148,300
|
)
|
|
|
(102,732
|
)
|
Permanent differences
|
|
|
(10,491
|
)
|
|
|
(39,088
|
)
|
|
|
(3,702
|
)
|
Change
in tax rates
|
|
|
169,750
|
|
|
|
99,278
|
|
|
|
110,690
|
|
Difference
between Canadian and foreign tax rates
|
|
|
(10,650
|
)
|
|
|
(30,102
|
)
|
|
|
(12,690
|
)
|
Other
|
|
|
32,924
|
|
|
|
34,650
|
|
|
|
12,566
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
The
change in valuation allowance for originating temporary differences and losses available for carry forward, is calculated using
an expected deferred tax rate of 12.43%, based on the application of the Small Business Deduction. The rate at which such amounts
may be realized as disclosed as part of a deferred tax asset and related valuation allowance takes into account the enacted tax
rate decreases over the expected period of realization.
Refundable
investment tax credits for research and development in Canada of $128,718, $171,204 and $124,234, for the years ended March
31, 2020, March 31, 2019 and March 31, 2018, respectively is netted against research and development expense. The investment tax
credits are subject to review and approval by taxation authorities and it is possible that the amounts granted will be different
from the amounts recorded by the Company.
Deferred
taxes reflect the impact of temporary differences between amounts of assets and liabilities for financial reporting purposes and
such amounts as measured by tax laws. The Company’s deferred tax assets are as follows:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
Losses available for carry forward
|
|
|
104,751
|
|
|
|
132,739
|
|
Property and equipment - differences in net book value and unamortized capital cost
|
|
|
64,094
|
|
|
|
69,560
|
|
Intangible assets - differences in net book value and tax basis
|
|
|
133,946
|
|
|
|
156,668
|
|
Unused scientific research and experimental development amounts deductible and investment tax credits available for carry forward
|
|
|
716,111
|
|
|
|
763,519
|
|
Other
|
|
|
2,960
|
|
|
|
79,789
|
|
Gross deferred tax asset
|
|
|
1,021,860
|
|
|
|
1,202,275
|
|
Valuation allowance
|
|
|
(1,021,860
|
)
|
|
|
(1,202,275
|
)
|
Net deferred tax asset
|
|
|
—
|
|
|
|
—
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
The
Company has federal and provincial non-capital losses available to reduce taxable income in Canada, which expire in the following
years:
|
|
Federal &
Provincial
|
|
|
|
|
2027
|
|
|
|
425,016
|
|
|
2028
|
|
|
|
288,255
|
|
|
2037
|
|
|
|
127,402
|
|
|
2038
|
|
|
|
2,172
|
|
|
2039
|
|
|
|
14,833
|
|
|
2040
|
|
|
|
122,358
|
|
|
|
|
|
|
980,036
|
|
The
Company has capital losses of $231,234, which are available indefinitely to reduce capital gains in future years as of March 31,
2020.
The
losses in Brazil of $236,260 have an indefinite carryforward period. However, the losses can only be used to offset 30% of taxable
income in any given year.
As
at March 31, 2020, the Company had accumulated unclaimed federal and provincial scientific research and experimental development
deductions of approximately $3,858,241 ($4,027,584 in 2019). This amount can be carried forward indefinitely to reduce income
taxes payable in future years.
The
Company has federal scientific research and experimental development credits available to reduce income taxes in Canada, which
expire in the following years:
|
2019
|
|
|
$
|
4,685
|
|
|
2020
|
|
|
|
—
|
|
|
2021
|
|
|
|
12,743
|
|
|
2022
|
|
|
|
249,680
|
|
|
2023
|
|
|
|
1,603
|
|
|
2024
|
|
|
|
2,007
|
|
|
2025 to 2033
|
|
|
|
8,787
|
|
|
|
|
|
$
|
279,505
|
|
16
– INCOME (LOSS) PER SHARE
For
the purposes of the income (loss) per share computation, the weighted average number of common shares outstanding has been used.
The
following securities are considered "in the money" and could potentially dilute the basic income (loss) per
share in the future but have not been included in diluted income (loss) per share because their effect was
antidilutive:
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
|
|
March 31, 2020
|
|
March 31, 2019
|
|
March 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
112,250
|
|
|
|
91,000
|
|
|
|
—
|
|
Total outstanding at March 31, 2020, 2019 and 2018 were 161,500, 170,250, and 204,150 respectively. Diluted income (loss) per
share for the years ended March 31, 2020, 2019 and 2018 is deemed to be identical to basic loss per share as exercise of the options
outstanding is antidilutive.
17
- FINANCIAL RISKS
The
Company operates internationally, giving rise to significant exposure to market risks from changes in foreign exchange rates.
The Company’s financial assets are in the form of cash and cash equivalents held at institutions with high quality credit
ratings, accounts receivable and investments. A hypothetical 10% change in the value of one Brazilian real expressed in U.S. dollars
during the year ended March 31, 2020 would have caused an approximate $7,589 change in the Company’s net loss for the fiscal
year 2020. The Company is exposed to exchange risk due to the timing of the movement of funds between subsidiaries and the parent
company related to the transfer pricing agreement and the pricing of contracts in non-functional currencies. Financial instruments
denominated in foreign currencies that lead to foreign exchange risk when funds are moved include:
Cash
and cash equivalents includes the following amounts in their source currency:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
|
|
Canadian dollars
|
|
|
266,005
|
|
|
|
131,463
|
|
U.S. dollars
|
|
|
6,638
|
|
|
|
153,406
|
|
Brazilian reals
|
|
|
1,223,708
|
|
|
|
1,013,757
|
|
Accounts
receivable include the following amounts receivable in their source currency:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
|
|
Canadian dollars
|
|
|
17,349
|
|
|
|
44,287
|
|
U.S. dollars
|
|
|
—
|
|
|
|
4,548
|
|
Brazilian reals
|
|
|
68,975
|
|
|
|
85,476
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
Accounts
payable include the following amounts payable in their source currency:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
|
|
Canadian dollars
|
|
|
19,085
|
|
|
|
44,537
|
|
U.S. dollars
|
|
|
—
|
|
|
|
3,275
|
|
Brazilian reals
|
|
|
772
|
|
|
|
772
|
|
Accrued
liabilities include the following accruals in their source currency:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
|
|
Canadian dollars
|
|
|
32,012
|
|
|
|
22,397
|
|
Brazilian reals
|
|
|
19,439
|
|
|
|
18,412
|
|
|
|
|
|
|
|
|
|
|
The
Company does not use derivative financial instruments to reduce its foreign exchange risk exposure.
CREDIT
RISK
The
Company is exposed to credit-related losses in the event of non-performance by counterparties to financial instruments. Credit
exposure is minimized by dealing with only creditworthy counterparties in accordance with established credit approval policies.
Concentration
of credit risk in accounts receivable is indicated below by the percentage of the total balance receivable from customers in the
specified geographic area:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
|
|
Canada
|
|
|
48
|
%
|
|
|
55
|
%
|
North America, excluding Canada
|
|
|
—
|
%
|
|
|
8
|
%
|
South America
|
|
|
52
|
%
|
|
|
37
|
%
|
|
|
|
100
|
%
|
|
|
100
|
%
|
FAIR
VALUE OF FINANCIAL INSTRUMENTS
The
carrying values of cash, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to the
relatively short periods to maturity of the instruments.
Investments
are fair valued in their source currency (Canadian dollars) based on objective evidence of fair value. The value is translated
to the reporting currency (U.S. dollars) at the exchange rate on March 31, 2020.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
18
– COMMITMENTS AND CONTINGENCIES
OPERATING
LEASE COMMITMENTS
The
Company has the following financial commitments related to minimum facilities lease expenses for facilities:
For
the year ended March 31, 2020, facilities expense was $36,994 ($39,113 for the year ended March 31,
2019 and $69,777 for the year ended March 31, 2018).
OTHER
The
Company is committed to pay an unrelated third party $75,000 upon the listing of ZIM Corporation’s common shares on a national
securities exchange.
19
- SUPPLEMENTAL CASH FLOW DISCLOSURE
|
|
Year ended
March 31, 2020
|
|
Year ended
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
Interest paid
|
|
|
(2,237
|
)
|
|
|
(2,378
|
)
|
Income taxes paid
|
|
|
—
|
|
|
|
—
|
|
Investment tax credit on research
and development received
|
|
|
132,109
|
|
|
|
171,204
|
|
20
- SEGMENT REPORTING
The
Company operates in two reportable segments based on product differentiation: mobile and software, maintenance and consulting.
Mobile applications involve providing SMS and other content applications and services for mobile devices. Software, maintenance
and consulting involves providing enterprise software for designing, developing and manipulating database systems and applications.
The
Company considers all revenues and expenses to be of an operating nature and accordingly, allocates them to the segments. Costs
specific to a segment are charged directly to the segment. Company operating expenses are allocated to either of the segments
based on gross revenues. Significant assets of the Company include working capital, an investment and equipment. The accounting
policies of the reportable segments are the same as those described in the summary of the significant accounting policies.
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
The
following table sets forth external revenues, cost of revenues (including depreciation expense), operating expenses (including
depreciation expense) and other amounts attributable to these segments:
Year ended March 31, 2020
|
|
Mobile
|
|
Software, Maintenance and Consulting
|
|
Total
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
Revenue
|
|
|
68,701
|
|
|
|
278,808
|
|
|
|
347,509
|
|
Cost of revenue
|
|
|
1,372
|
|
|
|
17,857
|
|
|
|
19,229
|
|
Gross margin
|
|
|
67,329
|
|
|
|
260,951
|
|
|
|
328,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of operating expenses
|
|
|
117,444
|
|
|
|
455,184
|
|
|
|
572,628
|
|
Allocation of interest income
|
|
|
(2,494
|
)
|
|
|
(9,666
|
)
|
|
|
(12,160
|
)
|
|
|
|
114,950
|
|
|
|
445,518
|
|
|
|
560,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before the following
|
|
|
(47,621
|
)
|
|
|
(184,567
|
)
|
|
|
(232,188
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on sale of investment
|
|
|
|
|
|
|
|
|
|
|
(220,233
|
)
|
Revaluation of investments
|
|
|
|
|
|
|
|
|
|
|
(2,956
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
(8,999
|
)
|
Year ended March 31, 2019
|
|
Mobile
|
|
Software, Maintenance and Consulting
|
|
Total
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
Revenue
|
|
|
122,638
|
|
|
|
577,411
|
|
|
|
700,049
|
|
Cost of revenue
|
|
|
2,071
|
|
|
|
18,517
|
|
|
|
20,588
|
|
Gross margin
|
|
|
120,567
|
|
|
|
558,894
|
|
|
|
679,461
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of operating expenses
|
|
|
105,387
|
|
|
|
488,527
|
|
|
|
593,914
|
|
Allocation of interest income
|
|
|
(2,476
|
)
|
|
|
(11,480
|
)
|
|
|
(13,956
|
)
|
|
|
|
102,911
|
|
|
|
477,047
|
|
|
|
579,958
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before the following
|
|
|
17,656
|
|
|
|
81,847
|
|
|
|
99,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revaluation of investments
|
|
|
|
|
|
|
|
|
|
|
(604,013
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
703,516
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
Year ended March 31, 2018
|
|
Mobile
|
|
Software, Maintenance and Consulting
|
|
Total
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
Revenue
|
|
|
108,485
|
|
|
|
394,757
|
|
|
|
503,242
|
|
Cost of revenue
|
|
|
2,886
|
|
|
|
12,888
|
|
|
|
15,774
|
|
Gross margin
|
|
|
105,599
|
|
|
|
381,869
|
|
|
|
487,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of operating expenses
|
|
|
128,183
|
|
|
|
463,536
|
|
|
|
591,719
|
|
Allocation of gain on sales of assets
|
|
|
(3,377
|
)
|
|
|
(12,214
|
)
|
|
|
(15,591
|
)
|
Allocation of dividend income
|
|
|
(9,912
|
)
|
|
|
(35,846
|
)
|
|
|
(45,758
|
)
|
|
|
|
114,893
|
|
|
|
415,477
|
|
|
|
530,370
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(9,294
|
)
|
|
|
(33,608
|
)
|
|
|
(42,902
|
)
|
The
following table sets forth total assets used by each segment:
TOTAL ASSETS
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
Mobile
|
|
|
263,676
|
|
|
|
268,115
|
|
Software, Maintenance and Consulting
|
|
|
1,070,073
|
|
|
|
1,262,352
|
|
Total assets
|
|
|
1,333,749
|
|
|
|
1,530,467
|
|
The
following tables set forth external revenues and long-lived assets attributable to geographic areas. External revenues are based
on the location of the customer:
|
|
March 31, 2020
|
|
March 31, 2019
|
|
|
|
$
|
|
|
|
$
|
|
Long-lived assets
|
|
|
|
|
|
|
|
|
Canada
|
|
|
16,017
|
|
|
|
19,220
|
|
Brazil
|
|
|
1,208
|
|
|
|
1,579
|
|
Total long-lived assets
|
|
|
17,225
|
|
|
|
20,799
|
|
ZIM CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED MARCH 31, 2020
(EXPRESSED IN US DOLLARS)
Total Revenue
|
|
Year ended March 31, 2020
|
|
Year ended March 31, 2019
|
|
Year ended March 31, 2018
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
|
55,548
|
|
|
|
235,591
|
|
|
|
34,076
|
|
Brazil
|
|
|
191,043
|
|
|
|
170,056
|
|
|
|
218,435
|
|
Canada
|
|
|
14,878
|
|
|
|
41,464
|
|
|
|
141,511
|
|
Singapore
|
|
|
68,907
|
|
|
|
22,775
|
|
|
|
108,485
|
|
Austria
|
|
|
17,133
|
|
|
|
130,163
|
|
|
|
735
|
|
Total revenue
|
|
|
347,509
|
|
|
|
700,049
|
|
|
|
503,242
|
|
Management
evaluates each segment’s performance based upon revenues and gross margins achieved.
21
– SUBSEQUENT EVENTS
On
June 5, 2020, ZIM Corporation announced the sale of its database technology business as part of management’s plan to focus
the business on its biomedical subsidiary NuvoBio. The database assets include all of the Software, Consulting and Maintenance
segment and have been purchased by members of Zim Corporation’s staff and will operate under the name Zim Databases Canada
Inc. The purchase price of $84,584 ($120,000 Canadian dollars) is to be paid in 5 equal payments over a 5-year period on the anniversary
date of the agreement.
On
May 20, 2020, ZIM Corporation entered into an operating lease for its head office in Ottawa, Ontario Canada. The lease is for
a period of 2 years and 1 month commencing on June 1, 2020. 24 monthly installments of minimum lease payments equal to $961 will
commence July 1, 2020. The first month of the lease is provided at no charge.